Pregnancy outcomes in patients with pulmonary hypertension remain poor despite
advanced therapies. Although consensus guidelines recommend against pregnancy in …

Pulmonary arterial hypertension (PAH) is a complex disorder in which pulmonary arterial
obstruction leads to elevated pulmonary arterial resistance and right ventricular failure …

OBJECTIVE: To identify whether pregnancy outcomes vary by etiology and severity of
pulmonary hypertension and whether contemporary therapies influence outcomes …

Pregnancies in patients with pulmonary arterial hypertension (PAH) are associated with
serious complications and mortality rates of more than 50%. Advanced medical therapies for …

Pregnancy with pulmonary hypertension is considered to be associated with increased
maternal and neonatal mortality. We retrospectively reviewed all parturients with pulmonary …

BACKGROUND Despite the development of advanced therapies for pulmonary arterial
hypertension, pregnancy remains contraindicated in these patients owing to high maternal …

Pulmonary arterial hypertension (PAH) is a rare and devastating disease characterized by
progressive increases in pulmonary arterial pressure and pulmonary vascular resistance …

Pulmonary hypertension (PH) is a heterogeneous disease characterized by an elevated
mean pulmonary artery pressure of 20 mm Hg or above. PH is a prevalent condition among …

Pulmonary arterial hypertension (PAH) is a pulmonary vasculopathy associated with
abnormal cardiopulmonary hemodynamics and a limited life expectancy due to right heart …

Pregnancy in patients with pulmonary arterial hypertension (PAH) is associated with a
maternal mortality of 30–50% despite modern treatment modalities. The majority of maternal …